Kymera Therapeutics is pivoting focus from oncology to immunology, with plans to only develop cancer programs beyond phase 1 studies via partnerships. | Kymera Therapeutics is pivoting its focus from ...
November is Eczema Awareness Month, and Eczema Society of Canada (ESC) has secured monuments and landmarks across Canada to light up blue to "shine a light" on the burden and impact of eczema and ...
Researchers have discovered a way that ovarian cancer tumors manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance. The study used a ...
Financing co-led by RA Capital Management and Sectoral Asset Management ?? Proceeds to support clinical development of lead program MRGPRX2 inhibitor, EVO756, as well as IL-18 t ...